LIANGRUN
Live / Registered — Registered (as of 29 Nov 2022)
What this means for you
Registered since 29 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88960979
- Registration number
- 6913578
- Mark type
- Stylized text
- Filed
- 11 Jun 2020
- Published for opposition
- 20 Oct 2020
- Registered
- 29 Nov 2022
- Attorney of record
- Nazly Aileen Bayramoglu
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; Chemical reagents for medical or veterinary purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Genetic identity tests comprised of reagents for medical purposes
Owner
- Shanghai Liangrun Biomedicine Technology Co.,Ltd., Shanghai, CN
- Shanghai Liangrun Biomedicine Technology Co.,Ltd., Shanghai, CN
- Shanghai Liangrun Biomedicine Technology Co.,Ltd., Shanghai, CN
Prosecution history
- 29 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 27 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Jul 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jun 2022 — USE AMENDMENT FILED
- 05 Jul 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 16 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Dec 2021 — SOU EXTENSION 2 GRANTED
- 14 Dec 2021 — SOU EXTENSION 2 FILED
- 14 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 27 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 May 2021 — SOU EXTENSION 1 GRANTED
- 25 May 2021 — SOU EXTENSION 1 FILED